Literature DB >> 21382398

The cholinergic hypothesis of cognitive aging revisited again: cholinergic functional compensation.

Julie A Dumas1, Paul A Newhouse.   

Abstract

It is now possible to reevaluate the cholinergic hypothesis of age-related cognitive dysfunction based on a synthesis of new evidence from cholinergic stimulation studies and cognitive models. We propose that a change of functional circuitry that can be observed through a combination of pharmacologic challenge and functional neuroimaging is associated with age-related changes in cholinergic system functioning. Psychopharmacological manipulations using cholinergic agonists and antagonists have been consistent in replicating patterns of aging seen in functional imaging studies. In addition, studies of anticholinesterase drugs in patients with Alzheimer's disease and mild cognitive impairment show support for the proposal that cholinergic compensation causes alterations in task-related brain activity. Thus, the cholinergic hypothesis of age-related cognitive dysfunction deserves further consideration as new methodologies for evaluating its validity are increasingly being used. Future directions for testing hypotheses generated from this model are presented.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21382398      PMCID: PMC3114182          DOI: 10.1016/j.pbb.2011.02.022

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  64 in total

1.  Neurophysiological correlates of age-related changes in working memory capacity.

Authors:  Venkata S Mattay; Francesco Fera; Alessandro Tessitore; Ahmad R Hariri; Karen F Berman; Saumitra Das; Andreas Meyer-Lindenberg; Terry E Goldberg; Joseph H Callicott; Daniel R Weinberger
Journal:  Neurosci Lett       Date:  2005-10-05       Impact factor: 3.046

Review 2.  More attention must be paid: the neurobiology of attentional effort.

Authors:  Martin Sarter; William J Gehring; Rouba Kozak
Journal:  Brain Res Rev       Date:  2006-03-13

3.  The modulatory effects of nicotine on parietal cortex activity in a cued target detection task depend on cue reliability.

Authors:  C Giessing; C M Thiel; F Rösler; G R Fink
Journal:  Neuroscience       Date:  2005-11-23       Impact factor: 3.590

4.  Cholinergic challenge in Alzheimer patients and mild cognitive impairment differentially affects hippocampal activation--a pharmacological fMRI study.

Authors:  Rutger Goekoop; Philip Scheltens; Frederik Barkhof; Serge A R B Rombouts
Journal:  Brain       Date:  2005-10-26       Impact factor: 13.501

Review 5.  Impulse control disorders in Parkinson's disease.

Authors:  Daniel Weintraub; Marc N Potenza
Journal:  Curr Neurol Neurosci Rep       Date:  2006-07       Impact factor: 5.081

Review 6.  Donepezil for mild cognitive impairment.

Authors:  J Birks; L Flicker
Journal:  Cochrane Database Syst Rev       Date:  2006-07-19

Review 7.  The correlative triad among aging, dopamine, and cognition: current status and future prospects.

Authors:  Lars Bäckman; Lars Nyberg; Ulman Lindenberger; Shu-Chen Li; Lars Farde
Journal:  Neurosci Biobehav Rev       Date:  2006-08-09       Impact factor: 8.989

Review 8.  Unraveling the attentional functions of cortical cholinergic inputs: interactions between signal-driven and cognitive modulation of signal detection.

Authors:  Martin Sarter; Michael E Hasselmo; John P Bruno; Ben Givens
Journal:  Brain Res Brain Res Rev       Date:  2005-02

9.  To treat or not to treat? A meta-analysis of the use of cholinesterase inhibitors in mild cognitive impairment for delaying progression to Alzheimer's disease.

Authors:  Breno Satler Diniz; Jony Arrais Pinto; Maria Luiza Cavichioli Gonzaga; Fabiana Meira Guimarães; Wagner Farid Gattaz; Orestes Vicente Forlenza
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-02-17       Impact factor: 5.270

10.  Scopolamine reduces persistent activity related to long-term encoding in the parahippocampal gyrus during delayed matching in humans.

Authors:  Karin Schon; Alireza Atri; Michael E Hasselmo; Marisa D Tricarico; Matthew L LoPresti; Chantal E Stern
Journal:  J Neurosci       Date:  2005-10-05       Impact factor: 6.709

View more
  51 in total

1.  Estradiol treatment altered anticholinergic-related brain activation during working memory in postmenopausal women.

Authors:  Julie A Dumas; Amanda M Kutz; Magdalena R Naylor; Julia V Johnson; Paul A Newhouse
Journal:  Neuroimage       Date:  2012-01-12       Impact factor: 6.556

Review 2.  Perimenopause and cognition.

Authors:  Gail A Greendale; Carol A Derby; Pauline M Maki
Journal:  Obstet Gynecol Clin North Am       Date:  2011-09       Impact factor: 2.844

3.  Kinetics modeling and occupancy studies of a novel C-11 PET tracer for VAChT in nonhuman primates.

Authors:  Hongjun Jin; Xiang Zhang; Xuyi Yue; Hui Liu; Junfeng Li; Hao Yang; Hubert Flores; Yi Su; Stanley M Parsons; Joel S Perlmutter; Zhude Tu
Journal:  Nucl Med Biol       Date:  2015-11-07       Impact factor: 2.408

4.  Anticholinergic Drug Use and Risk to Cognitive Performance in Older Adults with Questionable Cognitive Impairment: A Cross-Sectional Analysis.

Authors:  Sunil Swami; Ronald A Cohen; John A Kairalla; Todd M Manini
Journal:  Drugs Aging       Date:  2016-11       Impact factor: 3.923

Review 5.  Functional brain imaging of nicotinic effects on higher cognitive processes.

Authors:  Paul A Newhouse; Alexandra S Potter; Julie A Dumas; Christiane M Thiel
Journal:  Biochem Pharmacol       Date:  2011-06-13       Impact factor: 5.858

6.  Associations between genetic variations and global motion perception.

Authors:  Marina Kunchulia; Nato Kotaria; Karin Pilz; Adam Kotorashvili; Michael H Herzog
Journal:  Exp Brain Res       Date:  2019-08-20       Impact factor: 1.972

7.  The prominent role of stimulus processing: cholinergic function and dysfunction in cognition.

Authors:  Maura L Furey
Journal:  Curr Opin Neurol       Date:  2011-08       Impact factor: 5.710

Review 8.  Estrogen-cholinergic interactions: Implications for cognitive aging.

Authors:  Paul Newhouse; Julie Dumas
Journal:  Horm Behav       Date:  2015-07-14       Impact factor: 3.587

Review 9.  Rhinitis in the Elderly.

Authors:  Alan P Baptist; Sharmilee Nyenhuis
Journal:  Immunol Allergy Clin North Am       Date:  2016-03-04       Impact factor: 3.479

Review 10.  Recent Progress in the Pharmacotherapy of Alzheimer's Disease.

Authors:  Rita Khoury; Kush Patel; Jake Gold; Stephanie Hinds; George T Grossberg
Journal:  Drugs Aging       Date:  2017-11       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.